Lataa...
Fluoxetine for adults who are overweight or obese
BACKGROUND: Fluoxetine is a serotonin reuptake inhibitor indicated for major depression. It is also thought to affect weight control: this seems to happen through appetite changes resulting in decreased food intake and normalisation of unusual eating behaviours. However, the benefit‐risk ratio of th...
Tallennettuna:
| Julkaisussa: | Cochrane Database Syst Rev |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley & Sons, Ltd
2019
|
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6792438/ https://ncbi.nlm.nih.gov/pubmed/31613390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011688.pub2 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|